Metabolism
News
Drugs
Xagena Medicine
Xagena.net
Family environment is a significant predictor of adolescent obesity
Variants of the protein SH2-B might underlie obesity
Diabesity, increasing glucose processing in the liver can lower blood glucose
Diabesity: the fat connection
Weight loss drugs, the long-term health benefits remain unclear
Xenical approved for use in obese adolescents in Europe
Weight-loss surgery reduces heart disease risk
Long term efficacy of Bonviva, a once-monthly oral treatment for osteoporosis
Walk slowly appears useful for obese people
Orlistat improves weight management in obese adolescents
Screening for osteoporosis prevents hip fractures in older adults
Pramlintide produces progressive weight loss
Patients with metabolic syndrome and coronary calcium have greater chance of blocked arteries
Moderate exercise can reduce body fat without losing bone mass
Lifestyle critical for adult bone health
Insulin resistance, weight gain linked to premature aging
Obesity linked to colorectal and esophageal cancers
Fracture prevention with high dose vitamin D
Clinical applications of induced metabolic hibernation
Vitamin D, calcium supplements don’t reduce fracture risk
Sleep disturbances linked to metabolic syndrome
Osteoporosis, FDA approves once-monthly Ibandronate
Treatment for patients with the metabolic syndrome
Next Pages
1
2
[
3
]
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions
